What is Forbion European Acquisition Corp. (FRBN) stock price today?

Forbion European Acquisition Corp. (FRBN) is currently trading at $21.13, down 1.68% today.

What is FRBN return on equity (ROE)?

Forbion European Acquisition Corp.'s return on equity (ROE) is 0.00%, indicating how efficiently the company generates profit from shareholders' equity. This is below the typical market average of 12-15%.

What is Forbion European Acquisition Corp.'s market cap?

Forbion European Acquisition Corp. has a market capitalization of $334.12M.

NASDAQ · Shell Companies

Forbion European Acquisition Corp. (FRBN) Stock

$21.13 -1.68% NASDAQ: FRBN Financial Services

Forbion European Acquisition Corp. currently has no substantial business activities.

Valuation

Metric	Value
Price	$21.13
Market Cap	$334.12M
P/E Ratio	—
P/B Ratio	—
P/S Ratio	—
EPS (TTM)	—
52-Week High	$47.17
52-Week Low	$9.25
Dividend Yield	—

Financials & Margins

Metric	Value
ROE	0.00%
ROA	—
ROCE	-1.53%
Gross Margin	—
Operating Margin	—
Net Margin	—
Debt/Equity	0.00
Current Ratio	1.00

Annual Financials (USD)

Metric	2022
Revenue	—
Operating Profit	$-2.0M
Net Profit	$0
EPS	—
Op Margin	—

Balance Sheet (USD)

Metric	2021	2021	2022
Total Assets	—	$131.0M	$132.0M
Total Liabilities	—	$4.0M	$5.0M
Cash	—	$1.0M	$0
Borrowings	—	—	—

Cash Flow (USD)

Metric	2022
Operating Cash Flow	$-1.0M
Investing Cash Flow	$0
Financing Cash Flow	$0
Net Cash Flow	$-1.0M
Free Cash Flow	$-1.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	—
EV / EBITDA	—
FCF Yield	-0.30%
Quick Ratio	1.00
Interest Coverage	—
Return 1Y	—
Return 3Y	—
Return 5Y	—

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
CIIGCIIG Capital Partners II, Inc.	$8.75	+3.31%	-183.05	$314.45M	0.00%
CPUHCompute Health Acquisition Corp.	$10.36	-2.08%	25.90	$318.63M	0.00%
DNABSocial Capital Suvretta Holdings Corp. II	$10.36	+0.15%	41.42	$330.22M	0.00%
DNADSocial Capital Suvretta Holdings Corp. IV	$10.34	-0.09%	41.36	$329.75M	0.00%
HWELHealthwell Acquisition Corp. I	$10.48	+0.05%	28.31	$327.34M	0.00%

About Forbion European Acquisition Corp.

Forbion European Acquisition Corp. currently has no substantial business activities. Its primary purpose is to complete a strategic corporate transaction, such as a merger, stock exchange, asset acquisition, or restructuring, with other companies. The firm aims to pinpoint promising opportunities specifically within the European life sciences sector. Established in 2021, its registered office is located in Wilmington, Delaware.

Forbion European Acquisition Corp. is headquartered in US.

Forbion European Acquisition Corp. (FRBN) stock trades at $21.13 with a market capitalization of $334.12M. Over the past 52 weeks the stock has ranged between $9.25 and $47.17, and currently trades 55.2% below its 52-week high.

On profitability, Forbion European Acquisition Corp. generates a return on equity (ROE) of 0.00%, return on capital employed of -1.53%.

Official website: forbion.com/en/feac